Literature DB >> 23856840

Typing early Australian healthcare-associated MRSA: confirmation of major clones and emergence of ST1-MRSA-IV and novel ST2249-MRSA-III.

John F Lancashire1, Anna Jones, Haakon Bergh, Flavia Huygens, Graeme R Nimmo.   

Abstract

AIMS: To investigate the evolutionary origins of Australian healthcare-associated (HCA) methicillin-resistant Staphylococcus aureus (MRSA) strains from a panel of historical isolates typed using current genotyping techniques.
METHODS: Nineteen MRSA isolates from 1965 to 1981 were examined and antibiotic susceptibility profiles determined. Genetic characterisation included real-time (RT) polymerase chain reaction (PCR) assays to identify single nucleotide polymorhpism (SNP) clonal complexes (SNP CC) and sequence type (SNP ST), multi locus sequence typing (MLST) and staphylococcal chromosomal cassette mec typing.
RESULTS: All SNP CC30 isolates belonged to a novel sequence type, ST2249. All SNP CC239 isolates were confirmed as ST239-MRSA-III, except for a new single locus variant of ST239, ST2275. A further new type, ST2276, was identified.
CONCLUSIONS: The earliest MRSA examined from 1965 was confirmed as ST250-MRSA-I, consistent with archaic European types. Identification of ST1-MRSA-IV in 1981 is the earliest appearance of this clinically important lineage which manifested in Australia and the United States in the 1990s. A previously unknown multi-resistant clone, ST2249-MRSA-III, was identified from 1973. Gentamicin resistance first appeared in this novel strain from 1976 and not ST239 as previously suspected. Thus, ST2249 was present in the earliest phase of the HCA MRSA epidemic in eastern Australia and was perhaps related to the emergence of the globally epidemic strain ST239.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23856840     DOI: 10.1097/PAT.0b013e3283632667

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  5 in total

1.  ST2249-MRSA-III: a second major recombinant methicillin-resistant Staphylococcus aureus clone causing healthcare infection in the 1970s.

Authors:  G R Nimmo; J A Steen; S Monecke; R Ehricht; P Slickers; J C Thomas; S Appleton; R V Goering; D A Robinson; G W Coombs
Journal:  Clin Microbiol Infect       Date:  2015-01-28       Impact factor: 8.067

Review 2.  Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology.

Authors:  Sahreena Lakhundi; Kunyan Zhang
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

3.  Epidemiology of Staphylococcus aureus in a burn unit of a tertiary care center in Ghana.

Authors:  Nana Ama Amissah; Lieke van Dam; Anthony Ablordey; Opoku-Ware Ampomah; Isaac Prah; Caitlin S Tetteh; Tjip S van der Werf; Alexander W Friedrich; John W Rossen; Jan Maarten van Dijl; Ymkje Stienstra
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

4.  Genomic characterization of two community-acquired methicillin-resistant Staphylococcus aureus with novel sequence types in Kenya.

Authors:  John Njenga; Justin Nyasinga; Zubair Munshi; Angela Muraya; Geoffrey Omuse; Caroline Ngugi; Gunturu Revathi
Journal:  Front Med (Lausanne)       Date:  2022-09-26

5.  Methicillin Resistant Staphylococcus aureus Transmission in a Ghanaian Burn Unit: The Importance of Active Surveillance in Resource-Limited Settings.

Authors:  Nana Ama Amissah; Andrew H Buultjens; Anthony Ablordey; Lieke van Dam; Ampomah Opoku-Ware; Sarah L Baines; Dieter Bulach; Caitlin S Tetteh; Isaac Prah; Tjip S van der Werf; Alexander W Friedrich; Torsten Seemann; Jan Maarten van Dijl; Ymkje Stienstra; Timothy P Stinear; John W Rossen
Journal:  Front Microbiol       Date:  2017-10-06       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.